Kayne Anderson Rudnick Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43	Closed	-$5K	–	704
2022 Q1	$5K	Buy	43 +41	+2,050%	+$4.77K	﹤0.01%	569
2021 Q4	$0	Buy	+2	New	–	﹤0.01%	678
2021 Q1	–	Sell	-13	Closed	-$1K	–	751
2020 Q4	$1K	Buy	+13	New	+$1K	﹤0.01%	687